Arterial and Venous Thrombosis following Trauma and Major Orthopedic Surgery: Molecular Mechanisms and Strategies for Intervention

Abstract

A variety of harmful effects can be triggered by trauma and major orthopedic surgery. One of the key players involved in this process is thrombin. The clinical consequence of this process has, for several decades, been considered to be formation of deep vein thrombosis and pulmonary embolism. Controlling thrombin generation and activation has therefore been the goal of thromboprophylaxis regimens administered to patients suffering from trauma or undergoing major surgery. Protecting patients from venous thromboembolism has, for many years, been the main goal of preventive strategies. However, our knowledge of cell destruction and release of substances that may cause organ damage has expanded in recent years. Release of molecules such as RNA and histones from destroyed tissues may cause cell destruction and organ damage at distal sites if released in huge amounts and disseminated systemically. This new knowledge points toward an unmet need for therapies that prevent both vascular events and organ deterioration. This article briefly reviews molecular mechanisms associated with the occurrence of vascular events and cellular destruction in patients with major bone damage caused by trauma.

Keywords

trauma - thrombosis - RNA

• References

• 1 Eriksson BI, Dahl OE. Thromboembolism in orthopedic surgery: Scope of the problem. In: Llau JV, , ed. Thromboembolism in orthopedic surgery. London: Springer; 2013: 1-11
• 2 Syggelos SA, Aletras AJ, Smirlaki I, Skandalis SS. Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome. Biomed Res Int 2013; 2013: 230805
• 3 Gatto M, Iaccarino L, Ghirardello A , et al. Serpins, immunity and autoimmunity: old molecules, new functions. Clin Rev Allergy Immunol 2013; 45 (2) 267-280
• 4 Lie SA, Engesaeter LB, Havelin LI, Furnes O, Vollset SE. Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999. Acta Orthop Scand 2002; 73 (4) 392-399
• 5 Kikura M, Oikawa F, Yamamoto K , et al. Myocardial infarction and cerebrovascular accident following non-cardiac surgery: differences in postoperative temporal distribution and risk factors. J Thromb Haemost 2008; 6 (5) 742-748
• 6 Sheppeard H, Henson J, Ward DJ, O'Connor BT. A clinico-pathological study of fatal pulmonary embolism in a specialist orthopaedic hospital. Arch Orthop Trauma Surg 1981; 99 (1) 65-71
• 7 Gruber UF. Prevention of fatal pulmonary embolism in patients with fractures of the neck of the femur. Surg Gynecol Obstet 1985; 161 (1) 37-42
• 8 Bergqvist D, Mätzsch T, Burmark US , et al. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg 1988; 75 (9) 888-891
• 9 Perez JV, Warwick DJ, Case CP, Bannister GC. Death after proximal femoral fracture—an autopsy study. Injury 1995; 26 (4) 237-240
• 10 Dahl OE, Caprini JA, Colwell Jr CW , et al. Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost 2005; 93 (5) 860-866
• 11 Morrell MT, Dunnill MS. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968; 55 (5) 347-352
• 12 Hunt LP, Ben-Shlomo Y, Clark EM , et al; National Joint Registry for England, Wales and Northern Ireland. 90-day mortality after 409,096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 2013; 382 (9898) 1097-1104
• 13 Ryge C. Epidemiology study in major orthopaedic surgery. A prospective follow-up study of 500 total hip arthroplasty patients with focus on thromboembolic and surgical complications [Ph.D. dissertation]. Copenhagen, Denmark. Faculty of Health Sciences, University of Copenhagen; 2008
• 14 Parmet JL, Horrow JC, Pharo G, Collins L, Berman AT, Rosenberg H. The incidence of venous emboli during extramedullary guided total knee arthroplasty. Anesth Analg 1995; 81 (4) 757-762
• 15 Modig J, Busch C, Olerud S, Saldeen T. Pulmonary microembolism during intramedullary orthopaedic trauma. Acta Anaesthesiol Scand 1974; 18 (2) 133-143
• 16 Dahl OE, Molnar I, Vinje A , et al. Studies on coagulation, fibrinolysis, kallikrein-kinin and complement activation in systemic and pulmonary circulation during hip arthroplasty with acrylic cement. Thromb Res 1988; 50 (6) 875-884
• 17 Giercksky KE, Bjorklid E. Protection of rats by phospholipase C from Bacillus cereus against the effects of intravenous infusions of purified tissue thromboplastin. Scand J Haematol 1976; 17 (4) 305-311
• 18 Talsnes O, Hjelmstedt F, Dahl OE, Pripp AH, Reikerås O. Biochemical lung, liver and kidney markers and early death among elderly following hip fracture. Arch Orthop Trauma Surg 2012; 132 (12) 1753-1758
• 19 Biderman P, Einav S, Fainblut M, Stein M, Singer P, Medalion B. Extracorporeal life support in patients with multiple injuries and severe respiratory failure: a single-center experience?. J Trauma Acute Care Surg 2013; 75 (5) 907-912
• 20 Dahl OE, Johnsen H, Kierulf P , et al. Intrapulmonary thrombin generation and its relation to monomethyl methacrylate plasma levels during hip arthroplasty. Acta Anaesthesiol Scand 1992; 36 (4) 331-335
• 21 Dahl OE. Cardiorespiratory and vascular dysfunction related to major reconstructive orthopedic surgery. Acta Orthop Scand 1997; 68 (6) 607-614
• 22 Pripp AH, Talsnes O, Reikerås O, Engesæter LB, Dahl OE. The proportion of perioperative mortalities attributed to cemented implantation in hip fracture patients treated by hemiarthroplasty. Hip Int 2014; 24 (4) 363-368
• 23 Windecker S, Stortecky S, Meier B. Paradoxical embolism. J Am Coll Cardiol 2014; 64 (4) 403-415
• 24 Hari P, Pai RG, Varadarajan P. Echocardiographic evaluation of patent foramen ovale and atrial septal defect. Echocardiography 2014; ;doi: 10.1111/echo.12625 [Epub ahead of print]
• 25 Dahl OE, Pedersen T, Kierulf P , et al. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res 1993; 70 (6) 451-458
• 26 Lovering AT, Riemer RK, Thébaud B. Intrapulmonary arteriovenous anastomoses. Physiological, pathophysiological, or both?. Ann Am Thorac Soc 2013; 10 (5) 504-508
• 27 Park MS, Owen BA, Ballinger BA , et al. Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery 2012; 151 (6) 831-836
• 28 Lovren F, Verma S. Evolving role of microparticles in the pathophysiology of endothelial dysfunction. Clin Chem 2013; 59 (8) 1166-1174
• 29 Wu CL, Anderson GF, Herbert R, Lietman SA, Fleisher LA. Effect of postoperative epidural analgesia on morbidity and mortality after total hip replacement surgery in Medicare patients. Reg Anesth Pain Med 2003; 28 (4) 271-278
• 30 Yang LC, Wang CJ, Lee TH , et al. Early diagnosis of deep vein thrombosis in female patients who undergo total knee arthroplasty with measurement of P-selectin activation. J Vasc Surg 2002; 35 (4) 707-712
• 31 Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004; 93 (9) 1176-1178
• 32 Ray MJ, Crawford SA, Crawford RW, Jabur MK, Walters DL. Increased CD40 ligand expression on platelets is associated with cardiovascular events after total hip arthroplasty. J Thromb Haemost 2006; 4 (3) 695-697
• 33 Gialdini G, Nearing K, Bhave PD , et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014; 312 (6) 616-622
• 34 Talsnes O, Hjelmstedt F, Dahl OE, Pripp AH, Reikerås O. Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly. Int Orthop 2011; 35 (6) 903-907
• 35 Mandel P, Metais P. Les acides nucléiques du plasma sangiun chez l'homme. CR Acad Sci Paris 1948; 142: 241-243
• 36 Fischer S, Cabrera-Fuentes HA, Noll T, Preissner KT. Impact of extracellular RNA on endothelial barrier function. Cell Tissue Res 2014; 355 (3) 635-645
• 37 Kannemeier C, Shibamiya A, Nakazawa F , et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 2007; 104 (15) 6388-6393
• 38 Fischer S, Gerriets T, Wessels C , et al. Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood 2007; 110 (7) 2457-2465
• 39 Fischer S, Gesierich S, Griemert B , et al. Extracellular RNA liberates tumor necrosis factor-α to promote tumor cell trafficking and progression. Cancer Res 2013; 73 (16) 5080-5089
• 40 Fischer S, Nishio M, Dadkhahi S , et al. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb Haemost 2011; 105 (2) 345-355
• 41 Dahl OE. Thromboembolism and thromboprophylaxis in high risk surgery: facts and assumptions—a topic for emotions?. Eur J Anaesthesiol 2000; 17 (6) 343-347
• 42 Walberer M, Tschernatsch M, Fischer S , et al. RNase therapy assessed by magnetic resonance imaging reduces cerebral edema and infarction size in acute stroke. Curr Neurovasc Res 2009; 6 (1) 12-19
• 43 von Brühl ML, Stark K, Steinhart A , et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209 (4) 819-835
• 44 Tufano A, Coppola A, Cerbone AM, Ruosi C, Franchini M. Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost 2011; 37 (3) 252-266
• 45 Engesaeter LB, Dybvik E. Antithrombotic prophylaxis should start preoperatively in patients with hip fracture. Paper presented at: Annual Meeting of the Norwegian Orthopaedic Association; 2013; Oslo, Norway
• 46 Dahl OE, Gudmundsen TE, Pripp AH, Aanesen JJ. Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years. Clin Appl Thromb Hemost 2014; 20 (2) 117-123
• 47 Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370 (9601) 1773-1779
• 48 Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 2002; 96 (5) 1140-1146
• 49 Saffarzadeh M, Preissner KT. Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection. Curr Opin Hematol 2013; 20 (1) 3-9